Telecare Rehabilitation Program in Chronic Low Back Pain with Psychological Retention and Predominant Sociability
NCT ID: NCT05390762
Last Updated: 2024-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2022-05-03
2024-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional care in a day hospital
1. A common face to face day hospital, combining physical therapies with psychotherapeutic support such as Cognitive Behavioral Therapy to combat kinesiophobia.
2. A Second phase of 5 weeks of care face to face day hospital of the reconditioning type of 15 sessions.
Common phase
A common face to face day hospital combining physical therapies with psychotherapeutic support such as Cognitive Behavioral Therapy to combat kinesiophobia.
Care in Face to Face
A Second phase of 5 weeks of care in face to face day hospital of the reconditioning type of 15 sessions.
Telecare rehabilitation
1. A common face to face day hospital, combining physical therapies with psychotherapeutic support such as Cognitive Behavioral Therapy to combat kinesiophobia.
2. A Second phase of 5 weeks of Telecare rehabilitation of the reconditioning type of 15 sessions.
Common phase
A common face to face day hospital combining physical therapies with psychotherapeutic support such as Cognitive Behavioral Therapy to combat kinesiophobia.
Telecare rehabilitation
A Second phase of 5 weeks of telecare rehabilitation of the reconditioning type of 15 sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Common phase
A common face to face day hospital combining physical therapies with psychotherapeutic support such as Cognitive Behavioral Therapy to combat kinesiophobia.
Telecare rehabilitation
A Second phase of 5 weeks of telecare rehabilitation of the reconditioning type of 15 sessions.
Care in Face to Face
A Second phase of 5 weeks of care in face to face day hospital of the reconditioning type of 15 sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient treated for this pathology in a multidisciplinary program
* Dallas score \> 50% in anxiety/depression and sociability dimensions
* Patient who has given free and informed consent to participate in the research
* Patient affiliated to a social security scheme or beneficiary of such a scheme.
* Patient with an internet connection at home, allowing videoconferencing and a digital tool with web cam (tablet or computer).
Exclusion Criteria
* Cardiovascular risk factor contraindicating sports practice.
* Severe psychiatric pathology
* Low back pain of tumoral or inflammatory origin.
* Associated motor or sensory, neurological impairment.
* Disabling root irradiation
* Pregnant or breastfeeding women
* Patients under legal protection (guardianship, curators or safeguard of justice).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pôle Saint Hélier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jephté Houedakor
Role: PRINCIPAL_INVESTIGATOR
Pôle Saint Hélier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pôle Saint-Hélier
Rennes, Brittany Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00129-34
Identifier Type: -
Identifier Source: org_study_id